Aug 31, 2016 · Request permission View more assessments The Unified Dyskinesia Rating Scale captures the essential features of dyskinesia in Parkinson’s disease within a single scale, …

Mar 2, 2018 · The goal of this study was to validate an objective method of measuring levodopa induced dyskinesia in Parkinson's disease (PD).To characterize agreement between the …

Objective: To explore the relationship and rate of agreement between patient and clinician evaluation of dyskinesia severity and impact on function across multiple cultures. Background: …

The results suggest that it is feasible and clinically meaningful to utilize an objective full-body dyskinesia score for the assessment of dyskine severity, and the portable motion capture …

5 days ago · The 'What is the EPS number?' question is common in pharmacology. It refers to the scores on clinical rating scales like ESRS and AIMS, used to assess medication-induced …

Jul 16, 2021 · PTB and PTD fell in response to treatment for bradykinesia or dyskinesia (respectively) with greater sensitivity than clinical scales. This approach provides an objective …

Dyskinesia is a common side effect of prolonged dopaminergic therapy in Parkinson’s disease patients. Assessing the severity of dyskinesia can help develop better pharmacological and …

Apr 12, 2021 · Our objective in this paper was to develop a sensor-based dyskinesia assessment system that can measure dyskinesia severity in the home-living environment while PwPs …

Dyskinesia is a common side effect of prolonged dopaminergic therapy in Parkinson’s disease patients. Assessing the severity of dyskinesia could help develop better pharmacological and …

Abstract—A variety of clinical scales are available to assess dyskinesia severity in Parkinson’s disease patients; however, such assessments are subjective, do not provide long term …